文献速递垂体与肾上腺疾病

肢端肥大症:发病机制、诊断与管理

Acromegaly: pathogenesis, diagnosis, and management.
PubMed 文献 · Lancet Diabetes Endocrinol · 2022-10-06

本文综述肢端肥大症的流行病学、发病机制、诊断、并发症和治疗,强调以手术、药物治疗及偶用放疗的多模式策略实现IGF-1与生长激素正常化,并需个体化制定管理策略以优化结局。

要点

  • 生长激素分泌性垂体腺瘤多为散发性单克隆分化生长激素细胞增生,几乎均为良性但可局部侵袭。
  • 生长激素与IGF-1持续过量导致心血管、呼吸、代谢、骨骼肌肉、神经及肿瘤性共病,可能不可逆。
  • 主要治疗目标为IGF-1与生长激素正常化,需手术、药物及偶用放疗的多模式个体化管理。

核心结论

  • 肢端肥大症需以手术、药物治疗及偶用放疗的多模式策略实现IGF-1与生长激素正常化,并个体化制定管理策略以优化结局。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 生长激素分泌性垂体腺瘤多为散发性单克隆分化生长激素细胞增生,几乎均为良性但可局部侵袭。
  • 生长激素与IGF-1持续过量导致心血管、呼吸、代谢、骨骼肌肉、神经及肿瘤性共病,可能不可逆。

关键数值与推荐

  • 主要治疗目标为IGF-1与生长激素正常化;附加目标包括肿瘤缩小、缓解症状、管理并发症、降低超额发病率及改善生活质量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal expansions of differentiated somatotroph cells and are usually sporadic. They are almost invariably benign, yet they can be locally invasive and show progressive growth despite treatment. Persistent excess of both growth hormone and its target hormone insulin-like growth factor 1 (IGF-1) results in a wide array of cardiovascular, respiratory, metabolic, musculoskeletal, neurological, and neoplastic comorbidities that might not be reversible with disease control. Normalisation of IGF-1 and growth hormone are the primary therapeutic aims; additional treatment goals include tumour shrinkage, relieving symptoms, managing complications, reducing excess morbidity, and improving quality of life. A multimodal approach with surgery, medical therapy, and (more rarely) radiation therapy is required to achieve these goals. In this Review, we examine the epidemiology, pathogenesis, diagnosis, complications, and treatment of acromegaly, with an emphasis on the importance of tailoring management strategies to each patient to optimise outcomes.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Fleseriu M, Langlois F, Lim DST, et al. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2022. PMID: 36209758. doi:10.1016/S2213-8587(22)00244-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。